The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Preeclampsia: Pathophysiology, Diagnosis, and Management
Abstract
Preeclampsia, a major cause of fetal and maternal morbidity and mortality, may be difficult to distinguish clinically from other hypertensive disorders of pregnancy. Signs helpful in its diagnosis include presentation during late gestation in a nullipara with edema and proteinuria, and one or more of the following: hemoconcentration, hypoalbuminemia, liver function and/or coagulation abnormalities, and increased urate levels. Measures that may prove useful in differentiating preeclampsia from less dangerous forms of hypertension are decreased antithrombin III levels, increments in serum iron and carboxyhemoglobin, and decreases in urinary calcium. Major pathophysiological features of preeclampsia are decreased cardiac output, pulmonary capillary wedge pressure, and plasma volume; and marked increases in peripheral vascular resistance, as well as exaggerated pressor responses to endogenous angiotensin II and catecholamines. Renal hemodynamics decrease, in part as a result of a characteristic morphological lesion in glomeruli ("endotheliosis"), and there may be increased vascular permeability leading to albumin loss from the intravascular space. When gestation is advanced, termination is the treatment of choice; when temporization is required, several antihypertensive medications whose safety and efficacy have been tested in pregnant women are available. Magnesium sulfate remains the drug of choice for impending convulsions (the eclamptic phase of the disease). Finally, the etiology of preeclampsia remains unknown, but a popular theory suggests that alterations in prostaglandin metabolism may be responsible for the hypertension and coagulopathy in this disorder. In this respect, prophylactic treatment with low doses of aspirin, which decrease platelet thromboxane production but spare endothelial prostacyclin release, may decrease the incidence of preeclampsia in "high-risk" populations.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A similar pattern is observed for VEGF, stimulating angiogenesis and promoting capillary permeability,29 leading to expansion of the interstitium.30, 31”
From Hypoalbuminemia: Pathogenesis and Clinical Significance (2019) · cites this paper as [31]
Citations
Cites
Reid, I. A., Morris, B. J., & Ganong, W. F. (1978) · Annual Review of Physiology · doi:10.1146/annurev.ph.40.030178.002113 · Cited by 949
Sibai, B. M., Taslimi, M. M., El-Nazer, A., Amon, E., Mabie, B. C., & Ryan, G. M. (1986) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(86)90266-8 · Cited by 596
PREVENTION OF PRE-ECLAMPSIA BY EARLY ANTIPLATELET THERAPY
Beaufils, M., Donsimoni, R., Uzan, S., & Colau, J. C. (1985) · The Lancet · doi:10.1016/s0140-6736(85)92207-x · Cited by 470
The Parkland Memorial Hospital protocol for treatment of eclampsia: Evaluation of 245 cases
Pritchard, J. A., Cunningham, F. G., & Pritchard, S. A. (1984) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(84)90538-6 · Cited by 422
Fisher, K. A., Luger, A., Spargo, B. H., & Lindheimer, M. D. (1981) · Medicine · doi:10.1097/00005792-198107000-00002 · Cited by 374
Self-citationPreeclampsia is associated with a serum factor cytotoxic to human endothelial cells
Rodgers, G. M., Taylor, R. N., & Roberts, J. M. (1988) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(88)80169-8 · Cited by 278
Preeclampsia: a review of the role of prostaglandins.
Friedman, S. A. (1988) · PubMed · Cited by 255
PLACEBO-CONTROLLED TRIAL OF ATENOLOL IN TREATMENT OF PREGNANCY-ASSOCIATED HYPERTENSION
Rubin, P. C., Clark, D., Sumner, D., Low, R., Butters, L., Reynolds, B., Steedman, D. J., & Reid, J. L. (1983) · The Lancet · doi:10.1016/s0140-6736(83)91436-8 · Cited by 234
Taufield, P. A., Aleš, K. L., Resnick, L. M., Druzin, M. L., Gertner, J. M., & Laragh, J. H. (1987) · New England Journal of Medicine · doi:10.1056/nejm198703193161204 · Cited by 212
The relationship between calcium intake and pregnancy-induced hypertension: Up-to-date evidence
Belizán, J. M., Villar, J., & Repke, J. T. (1988) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(88)90091-9 · Cited by 208
Cited by
Sorted by citations
Hypoalbuminemia: Pathogenesis and Clinical Significance
Soeters, P. B., Wolfe, R. R., & Shenkin, A. (2019) · Journal of Parenteral and Enteral Nutrition · doi:10.1002/jpen.1451 · Cited by 1,448
Kell, D. B. (2009) · BMC Medical Genomics · doi:10.1186/1755-8794-2-2 · Cited by 554
(1990) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(90)90653-o · Cited by 441
Schwartz, R. B., Feske, S. K., Polak, J. F., Girolami, U. D., Iaia, A., Beckner, K. M., Bravo, S. M., Klufas, R. A., Chai, R. Y., & Jt, R. (2000) · Radiology · doi:10.1148/radiology.217.2.r00nv44371 · Cited by 388
Remuzzi, G., & Ruggenenti, P. (2012) · SpringerReference · doi:10.1007/springerreference_226547 · Cited by 267
Metadata
- Authors
- Lindheimer, M. D., & Katz, A. I.
- Affiliations
- University of Chicago (US)
- Venue
- Annual Review of Medicine
- Publisher
- Annual Reviews
- Published
- 1989-02
- Volume
- 40
- Issue
- 1
- Pages
- 233-250
- ISSN
- 0066-4219 (ISSN-L)
- 1545-326X
- OpenAlex
- W2115403364
- Cited by
- 128
- References
- 47
- Citations by year
- 2025: 1 · 2024: 1 · 2023: 1 · 2022: 2 · 2021: 6 · 2020: 5 · 2019: 5 · 2018: 8 · 2017: 1 · 2016: 11 · 2015: 2 · 2014: 7 · 2013: 6 · 2012: 4
- FWCI
- 12.92
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Annual Review of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (HD-24498)
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Pregnancy and preeclampsia studies
- Health Sciences › Medicine › Clinical Neurology › Neurological Complications and Syndromes
- Health Sciences › Medicine › Obstetrics and Gynecology › Pregnancy-related medical research
- Keywords
- preeclampsia, hypertensive disorders of pregnancy, pathophysiology, proteinuria, endotheliosis, antithrombin III, magnesium sulfate, eclampsia, antihypertensive drugs in pregnancy, aspirin prophylaxis, prostaglandin metabolism, thrombocytopenia, systemic vascular resistance, abortion
- MeSH terms
- Antihypertensive Agents, Diagnosis, Differential, Eclampsia, Female, Hemodynamics, Humans, Magnesium Sulfate, Pre-Eclampsia, Pregnancy, Dinoprostone
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review